Israel - Ibrani - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

Israel - Ibrani - Ministry of Health

kamada ltd, israel - factor viii; von willebrand factor - אבקה להכנת תמיסה לזריקה - factor viii 500 iu/vial; von willebrand factor 1300 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

Israel - Ibrani - Ministry of Health

kamada ltd, israel - factor viii; von willebrand factor - אבקה להכנת תמיסה לזריקה - factor viii 1000 iu/vial; von willebrand factor 2600 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

Israel - Ibrani - Ministry of Health

kamada ltd, israel - albumin human - תמיסה לאינפוזיה - albumin human 45 mg/ml - albumin - albumin - for restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

Israel - Ibrani - Ministry of Health

kamada ltd, israel - albumin human - תמיסה לאינפוזיה - albumin human 200 mg/ml - albumin - albumin - for restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

Israel - Ibrani - Ministry of Health

kamada ltd, israel - albumin human - תמיסה לאינפוזיה - albumin human 200 mg/ml - albumin - albumin - for restoration and maintenance of circulating blood volume where volume deficiency has been demontrated and use of a colloid such as albumin is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient based on official recommendations.

Israel - Ibrani - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה לאינפוזיה - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

Israel - Ibrani - Ministry of Health

kamada ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 5 g / 100 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, and children and adolescents in:- primary immunodeficiency syndromes with impaired antibody production - hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed- hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation- congenital aids with recurrent bacterial infectionsimmunomodulation in adults, and children and adolescents in:- primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count- guillain barr? syndrome- kawasaki disease

Israel - Ibrani - Ministry of Health

kamada ltd, israel - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - 1.replacement therapy in: primary immunodeficiency syndromes such as: - congenital agammaglobulinemia and hypogammaglobulinemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinemia and recurrent infectionschildren with congenital aids and recurrent infections2. immunomodulation: - idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count- guillain barr? syndrome- kawasaki disease3. allogeneic bone marrow transplantation

Israel - Ibrani - Ministry of Health

kamada ltd, israel - methacholine chloride - אבקה להכנת תמיסה לאינהלציה - methacholine chloride 100 mg/vial - for the diagnosis of bronchial airway hyperactivity in subjects who do not have clinically apparent asthma.